KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹84 Cr | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹84 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹73 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹84 Cr | 31.29 | |
| Mar2024 | ₹64 Cr | -6.76 | |
| Mar2023 | ₹69 Cr | -0.59 | |
| Mar2022 | ₹69 Cr | -5.51 | |
| Mar2021 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹592.7 Cr | -4.8% | 4.8% | 3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -4.8% |
4.8% |
3.6% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses